On the balance of probabilities was a smart move. Infant Formula market is hot. BAL 1st half expectations are for 15% decline. Forward expectations are very high 30% growth onwards.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025